ReviewFrontiers in immunology2023
Interleukin-17-targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile.
Rubén Queiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it